Roche Diabetes Care GmbH v.Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V.
Paris (FR) Central Division - Seat · UPC-000741
This is a cost decision by the Court of First Instance of the Unified Patent Court (Central Division, Paris seat) following a revocation action concerning European patent EP 2 196 231 B1. Roche Diabetes Care GmbH, the successful party in the revocation proceedings, sought reimbursement of its costs from Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V. The Court dismissed the respondents' request to stay the cost proceedings pending appeal, resolved an inconsistency in the amount claimed, and determined the recoverable costs at EUR 117,741.62.